GREENZ

[DFLY]

VRX BAMMMO GZ! DRUG APPROVED! GAME ON MANANA AMFE VRX WHOAA!))




FDA Approves Valeant''s Siliq To Treat Plaque Psoriasis

February 15, 2017, 09:22:00 PM EDT By RTT News


(RTTNews.com) - The U.S. Food and Drug Administration approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Siliq is marketed by Bridgewater, New Jersey-based Valeant Pharmaceuticals (VRX, VRX.TO).

Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken by mouth or injected) or phototherapy (ultraviolet light treatment) and have failed to respond, or have stopped responding to other systemic therapies.

Psoriasis is a skin condition that causes patches of skin redness and flaking. Psoriasis is an autoimmune disorder that occurs more commonly in patients with a family history of the disease, and most often begins in people between the ages of 15 and 35. The most common form of psoriasis is plaque psoriasis, in which patients develop thick, red skin with flaky, silver-white scales.





The most common adverse reactions reported with the use of Siliq include joint pain (arthralgia), headache, fatigue, diarrhea, throat pain (oropharyngeal pain), nausea, muscle pain (myalgia), injection site reactions, influenza, low white blood cell count (neutropenia) and fungal (tinea) infections.

For comments and feedback: contact


Read more: http://www.nasdaq.com/article/fda-approves-valeants-siliq-to-treat-plaque-psoriasis-20170215-01681#ixzz4Yob9Q9yL